Skip to main content
RPbio Inc. logo

RPbio Inc. — Investor Relations & Filings

Ticker · 314140 ISIN · KR7314140005 KO Manufacturing
Open in API
Filings indexed 93 across all filing types
Latest filing 2020-04-08 Audit Report / Informat…
Country KR South Korea
Listing KO 314140

About RPbio Inc.

https://rpbio.co.kr/html/en/main.php

RPbio Inc. is a bio-health company specializing in the development and production of pharmaceuticals and health functional foods. Established in 1983 as a joint venture with RP Scherer, the company is a leading producer of soft capsules, leveraging extensive technological expertise. RPbio operates as a Contract Development and Manufacturing Organization (CDMO), providing comprehensive services that include research and development, raw material sourcing, manufacturing of finished drugs, and OEM/ODM for health supplements. The company focuses on advancing softgel technologies and offers integrated solutions, including regulatory support, to its global partners in the pharmaceutical and health sectors.

Recent filings

Filing Released Lang Actions
감사보고서 (2019.12)
Audit Report / Information Classification · 100% confidence The document is a comprehensive 'Audit Report' (감사보고서) for the company 'RP Bio' (주식회사 알피바이오). It includes the independent auditor's opinion, financial statements (Balance Sheet, Income Statement, Statement of Changes in Equity, Cash Flow Statement), and detailed notes to the financial statements. It covers the fiscal years 2018 and 2019. While it contains financial data, it is the formal audit report rather than a 10-K (which is a specific US regulatory filing) or a simple earnings release. Given the structure and content, it fits the 'Audit Report' category. FY 2019
2020-04-08 Korean
[기재정정]감사보고서 (2018.12)
Audit Report / Information Classification · 100% confidence The document is a formal 'Audit Report' (감사보고서) for the company 'RP Bio' (주식회사 알피바이오). It includes the independent auditor's report, financial statements (balance sheet, income statement, statement of changes in equity, cash flow statement), and detailed notes to the financial statements. It is a comprehensive financial document covering the fiscal year 2018, not an announcement or a summary. Therefore, it is classified as an Audit Report. FY 2018
2019-04-09 Korean
감사보고서 (2018.12)
Audit Report / Information Classification · 100% confidence The document is a formal 'Audit Report' (감사보고서) for the company 'RP Bio' (주식회사 알피바이오) for the fiscal years 2017 and 2018. It includes the independent auditor's opinion, financial statements (balance sheet, income statement, statement of changes in equity, cash flow statement), and detailed notes to the financial statements. While it contains financial data, it is a standalone audit report rather than a full 10-K annual report or a simple earnings release. Therefore, it fits the 'Audit Report / Information' (AR) category. FY 2018
2019-04-08 Korean

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.